Loading clinical trials...
Loading clinical trials...
The overarching goal of the current study is to investigate the effect of GLP-1 on brain insulin responsiveness in a randomized, single-blinded, within subject cross-over study design. To this end, in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital Tuebingen
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT04805502 · Pregnancy, Overweight and Obesity
NCT07109245 · Brain Insulin Sensitivity, Healthy Controls, and more
NCT06688461 · Type 2 Diabetes, Lifestyle-related Condition, and more
NCT06555393 · High Blood Sugar, High Blood Pressure, and more
University Clinic Tubingen, Department of Internal Medicine IV
Tübingen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions